Pfizer Inc. reported earnings results for the first quarter ended March 30, 2025. For the first quarter, the company reported revenue was USD 13,715 mi...
Lilly Oncology Competitors or Alternatives
Lilly Oncology's top competitors include G1 Therapeutics, Kite Pharma and bluebird bio.
Lilly Oncology VS G1 Therapeutics
G1 Therapeutics is Lilly Oncology's #1 rival. G1 Therapeutics was founded in 2008 in Research Triangle Park, North Carolina. Like Lilly Oncology, G1 Therapeutics also operates in the Pharmaceuticals & Biotechnology space. G1 Therapeutics generates $56.2M more revenue than Lilly Oncology.
Lilly Oncology VS Kite Pharma
Kite Pharma is one of Lilly Oncology's top competitors. Kite Pharma is headquartered in Santa Monica, California, and was founded in 2009. Like Lilly Oncology, Kite Pharma also works within the Pharmaceuticals & Biotechnology sector. Kite Pharma generates 2,250% the revenue of Lilly Oncology.
Lilly Oncology VS bluebird bio
bluebird bio is seen as one of Lilly Oncology's top competitors. bluebird bio was founded in 1992, and its headquarters is in Somerville, Massachusetts. Like Lilly Oncology, bluebird bio also works within the Pharmaceuticals & Biotechnology sector. bluebird bio has 480 more employees than Lilly Oncology.
Looking for similar companies to Lilly Oncology?
Similar Companies
Pharmaceuticals companies in Indianapolis
See 35 companies
Pharmaceuticals companies in Indianapolis Metropolitan AreaSee 83 companies
Pharmaceuticals & Biotechnology companies in IndianapolisSee 81 companies
Pharmaceuticals companies in IndianaSee 119 companies
Pharmaceuticals & Biotechnology companies in Indianapolis Metropolitan AreaSee 159 companies
Pharmaceuticals & Biotechnology companies in IndianaSee 229 companies
Pharmaceuticals companies with revenue in $100K-5.0M rangeSee 2,201 companies
Companies in Indianapolis with revenue in $100K-5.0M rangeSee 2,447 companies
Pharmaceuticals companies with employees in 25-100 rangeSee 2,867 companies
Trending News for Lilly Oncology and Lilly Oncology's Competitors
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to bringing a...
Novartis AG NVS reported first-quarter 2025 adjusted earnings per share of $2.28, beating the street view of $2.10 . Quarterly sales of $13.23 billion ...
Bristol Myers Squibb (NYSE:BMY) recently reported its first-quarter results, with adjusted earnings of $1.80 per share on revenue of $11.2 billion. Thi...
Eli Lilly And Co LLY is scheduled to report its quarterly results on Thursday. The company is likely to report its first-quarter results in line with p...
Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy, "which we are unable to predict at this time."...
Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs....
In This Article: Abbott Laboratories recently announced promising results from its AVEIR Conduction System Pacing study, showcasing its innovative lead...
Investor focus is likely to be on the sales numbers of LLY's tirzepatide medicines Mounjaro and Zepbound....
Frequently Asked Questions about Lilly Oncology
Who are Lilly Oncology's top competitors?
Lilly Oncology's top 3 competitors are G1 Therapeutics, Kite Pharma, bluebird bio.Who is similar to Lilly Oncology?
G1 Therapeutics is the most similar to Lilly Oncology. Kite Pharma and bluebird bio are also similar to Lilly Oncology.
Are Lilly Oncology and G1 Therapeutics competitors?
Yes, G1 Therapeutics is one of Lilly Oncology’s top competitors.